Background/Objectives: We aimed to assess the effects on mild morbidity of a richly micronutrient-fortified complementary/ replacement food given to Zambian infants aged 6-18 months. Previous results (The Chilenje Infant Growth, Nutrition and Infection Study Team, 2010) showed an increase in the rate of hospital referral for pneumonia in the same cohort. Subject/Methods: A total of 743 six-month-old healthy Zambian infants were randomised to receive either a richly or a basal micronutrient-fortified porridge for 12 months. Mild morbidity was defined as an illness that did not cause death or require hospitalisation and was diagnosed on clinical examination at scheduled visits. Results: There was no evidence of an effect of trial arm on overall mild morbidity during the study (odds ratio (OR) ¼ 1.04, 95% confidence interval (CI) ¼ 0.90, 1.20, P ¼ 0.62). Infants in the richly fortified arm had significantly more visits in which they were diagnosed with lower respiratory tract infections/pneumonia (OR ¼ 1.65, 95% CI ¼ 1.06, 2.59, P ¼ 0.03) and fewer visits in which a diagnosis of urinary tract infection was made (OR ¼ 0.43, 95% CI ¼ 0.21, 0.87, P ¼ 0.02). Maternally reported symptoms were similar between trial arms. Conclusion: Compared with the basal diet, the richly micronutrient-fortified food was associated with more episodes of lower respiratory infections/pneumonia diagnosed at scheduled visits, which reinforces our previously reported findings of a higher incidence in hospital referral for pneumonia.
Introduction
Micronutrient deficiencies are common in young children in developing countries and have been associated with increased morbidity and mortality (Black et al., 2008) . However, supplementation with some micronutrients, notably iron, may also increase infections (Sazawal et al., 2006) ; hence World Health Organisation suggests micronutrient fortification may be preferable (WHO, 2006) .
We conducted a clinical trial in Zambia of the efficacy of two locally produced complementary/replacement foods, fortified with different levels of micronutrients, for infants aged 6 to 18 months. Hospital referral was one of the primary outcomes of the trial and results of the primary outcomes have been published (The Chilenje Infant Growth, Nutrition and Infection (CIGNIS) Study Team, 2010) . The overall rate of hospital referral was not different between trial arms, but there were significantly more referrals for pneumonia in the richly fortified porridge arm (CIGNIS Study Team, 2010) . To further investigate this finding, we analysed the effect of trial arm on mild morbidity during the trial as a secondary outcome. Mild morbidity was ascertained through clinical examinations at each scheduled visit. We also describe infants' clinical symptoms reported by the mothers.
Materials and methods
The Chilenje Infant Growth, Nutrition and Infection Study (CIGNIS) was a randomised double-blind controlled trial conducted from October 2005 to July 2009 in Lusaka, Zambia, comparing two locally produced complementary/ replacement foods, similar in bulk ingredients and macronutrient content but different in micronutrient content (CIGNIS Study Team, 2010) . Healthy infants (n ¼ 743) aged 6 months were randomised to receive one of the two porridges for 12 months (Table 1) . A detailed description of the trial design, methods and a flow chart of trial participants has been previously published (CIGNIS Study Team, 2010) .
Mild morbidity assessment
At all scheduled monthly visits, the clinical officer (JS) examined children, diagnosed and treated them according to the Integrated Management of Childhood Illness (WHO, 1998) . Mild morbidity was defined as a morbidity episode that did not cause death or did not require referral to the local tertiary care hospital. Infants were referred to tertiary facility when exhibiting danger signs (unable to drink or breastfeed, severe vomiting, convulsions, respiratory distress, lethargic or unconscious), when requiring surgery or when repeatedly presenting with an intractable illness requiring specialist consultation. At each scheduled visit, the main cause of illness was recorded as main diagnosis. Other collateral clinical conditions present at the time of examination were recorded as secondary diagnoses. Cases that were hospitalised within 7 days from the visit at the study clinic because of worsening conditions were excluded, as data on severe illness has been previously reported (CIGNIS Study Team, 2010) .
Classification and treatment of illness was based on local practice and international guidelines. If malaria was suspected from history or clinical presentation, thick and thin Giemsa-stained blood smears were taken, and malaria was diagnosed if parasites were detected by microscopic examination. Negative results were reported only after examining at least 200 oil immersion visual fields at a magnification of Â 1000 on both thick and thin smears (Moody and Chiodini, 2000) . Diarrhoea was defined as at least three loose stools or one bulky watery stool in the past 24 h. Lower respiratory tract infection (LRTI) included pneumonia and other types of infections, such as acute bronchitis or bronchiolitis. Pneumonia was defined as history of cough or difficulty breathing plus rapid breathing (X50 breaths/minute for infants aged o12 months and X40 breaths/minute for older children) with or without subcostal recession. Urinary tract infection (UTI) was diagnosed by urinalysis in presence of clinical symptoms (fever, diarrhoea and dysuria; WHO 2005). Otitis media was diagnosed on the basis of clinical symptoms (child tugging at the ear or irritable and fever) and abnormal otoscopic findings.
Reported symptoms
At 9-, 12-, 15-and 18-month visits, mothers were asked whether their child had presented specific symptoms in the past 3 days, using a questionnaire.
Data management and statistical methods
The primary outcome in this paper was the prevalence of any mild morbidity during the follow-up period (months 7-18). To assess the effect of trial arm on prevalence of mild morbidity during the study, we calculated the proportion of visits at which any mild morbidity was diagnosed separately for the two trial arms. We analysed these repeated measurements of mild morbidity using random effect logistic regression to account for within-individual correlation (Wang and Fox, 2006) and estimated the odds ratio (OR) and 95% confidence interval (CI) for the effect of trial arm (Rabe-Hesketh and Skrondal, 2008) . Secondary analyses of mild morbidity were adjusted for a priori confounders, selected because of their known association with child illnesses: child age, sex, maternal education and socioeconomic status. In addition, we estimated the effect of trial arm on specific illnesses (that is, upper respiratory tract infection, malaria, diarrhoea and so on; recorded as either the main or secondary diagnosis) and with reported symptoms.
It is possible that it may take some time for the intervention to have an effect on mild morbidity. Therefore, Based on estimated amounts of micronutrients that would be available from 50 g porridge flour/day made with maize fortified at levels planned nationally for Zambia. Overages (usually 10%) added to allow for losses during processing. b Based on total estimated micronutrient needs of infants aged 9-11 months minus amounts expected from low breast milk intakes (Dewey and Brown, 2003) and assuming intake of 50 g porridge flour/day. Exceptions to the micronutrient levels are that vitamin C was increased to compensate for low iron bioavailability and zinc was based on Recommended Daily Allowance set by the International Zinc Consultative Group (International Zinc Nutrition Consultative Group, 2004) . Overages (usually 10%) added to allow for losses during processing. we also examined whether the intervention effect on both, any mild morbidity and specific illnesses, changed with child age by including an interaction term between the intervention arm and child age in the random effect logistic regression model. Additionally, we assessed whether the effect of intervention arm on any mild morbidity during the study, and on specific illnesses, was modified by sex and anaemia at baseline (haemoglobin o105 g/l). STATA 11 (Statacorp, College Station, TX, USA) was used for data cleaning and analysis.
Results
As already described in the analysis of the primary trial outcomes, trial arms were substantially balanced at baseline with respect to child age and sex and maternal sociodemographic characteristics (CIGNIS Study Team, 2010) . Of the 743 healthy infants randomised at 6 months, 33 were lost to follow-up before the first monthly visit (7 month). The remaining 710 infants, included in the analyses presented here, were followed up for a total of 7355 scheduled visits, during which 1256 mild morbidity episodes were diagnosed in 552 infants. The most frequent diagnosis was upper respiratory tract infection (49% of episodes), followed by malaria (18%) and acute diarrhoea (16%). There was no evidence of an effect of trial arm on overall mild morbidity during the study (OR ¼ 1.04, 95% CI ¼ 0.90, 1.20, P ¼ 0.62; Table 2 ). However, the richly fortified arm had more visits in which LRTI/pneumonia was diagnosed (OR ¼ 1.65, 95% CI ¼ 1.06, 2.59, P ¼ 0.03) and fewer visits in which a diagnosis of urinary infection was made (OR ¼ 0.43, 95% CI ¼ 0.21, 0.87, P ¼ 0.02) compared with the basal-fortified arm. The effect of trial arm on overall mild morbidity was not different according to child age (P-value for interaction ¼ 0.20). There was also no evidence that the effect of trial arm on overall mild morbidity was different between males and females (P-value for interaction ¼ 0.35) and between anaemic and non-anaemic infants at baseline (P-value for interaction ¼ 0.55). The same interactions were also tested for the effect of intervention arm on specific illnesses, including LRTI/pneumonia and UTI, but none was statistically significant (data not shown).
The proportion of infants whose mothers reported symptoms in the past 3 days was slightly lower in the richly fortified group for all symptoms, although there was no evidence of a true difference (Table 3) .
Discussion
In the CIGNIS Trial, infants in the richly fortified arm had more visits in which LRTI/pneumonia was diagnosed. This result supports our previous observation of an increase in hospital admissions for severe pneumonia among infants receiving the richly fortified porridge: we recorded 21 hospital admissions for severe pneumonia in 370 infants in the richly fortified arm compared with 8 in 373 infants in the basal-fortified group (hazards ratio ¼ 2.68, 95% CI ¼ 1.17, 6.11, P ¼ 0.02; CIGNIS Study Team, 2010) . It is possible that specific components or nutrients in the porridge were responsible for the observed frequency of pneumonia, and iron has previously been shown to lead to an increase in some infections. In a trial conducted in Pemba, Zanzibar, iron-folic acid supplementation (with or without zinc) significantly increased the risk of morbidity and death due to non-malarial infections, but the specific effect of the intervention on LRTI/pneumonia was not evaluated (Sazawal et al., 2006) .
We also observed significantly higher haemoglobin levels at 18 months in the richly fortified arm compared with the basal arm (mean increase 5.53 g/l, 95% CI ¼ 3.55, 7.51, Po0.001) in the CIGNIS Trial and a better iron status (mean increase in ferritin level: 0.49 mg/l, 95% CI ¼ 0.36, 0.62, Po0.001; mean Table 2 Mild morbidity episodes on examination at monthly scheduled visits, and specific illness diagnosed, by trial arm Team, 2010) . However, it is not possible to determine whether increased iron was responsible for the increased frequency of pneumonia as multiple micronutrients were enhanced in our richly fortified porridge. Children in the richly fortified arm experienced fewer visits in which a diagnosis of UTIs was made. In a study in pregnant women, 100 mg daily of vitamin C was able to reduce occurrence of UTIs (Head, 2008) . There appear to be no equivalent studies in children. Although our richly fortified porridge contained a higher vitamin C content compared with the basal porridge, it is not possible to determine whether this was responsible for the difference in UTIs as multiple micronutrients were enhanced.
In conclusion, there was no difference between trial arms in the prevalence of overall mild morbidity during the study, as detected on examination at scheduled visits. However, there was some suggestion of a higher prevalence of LRTI/ pneumonia and a lower prevalence of UTIs in infants receiving richly micronutrient-fortified porridge. The effect of micronutrient fortification on LRTI and UTIs in infancy should be investigated further, especially given the potential safety problems of iron supplementation (WHO, 2006) . 
